Works matching IS 00099236 AND DT 2023 AND VI 113 AND IP 6
Results: 26
ASCPT News.
- Published in:
- 2023
- Publication type:
- Proceeding
The Impact of Longitudinal Data‐Completeness of Electronic Health Record Data on the Prediction Performance of Clinical Risk Scores.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1359, doi. 10.1002/cpt.2901
- By:
- Publication type:
- Article
Assessment of the Impact of Mandated Postmarketing Pediatric‐Focused Safety Reviews on Safety‐Related Regulatory Actions 2013–2019.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1368, doi. 10.1002/cpt.2900
- By:
- Publication type:
- Article
Clinical Significance of Therapeutic Peptide and Protein Drug Interactions: A Call to Action.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1173, doi. 10.1002/cpt.2899
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1175, doi. 10.1002/cpt.2898
- Publication type:
- Article
Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose (ATOM‐7).
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1304, doi. 10.1002/cpt.2888
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1171, doi. 10.1002/cpt.2896
- Publication type:
- Article
Factors Influencing COVID‐19 Risk: Insights From Molnupiravir Exposure‐Response Modeling of Clinical Outcomes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1337, doi. 10.1002/cpt.2895
- By:
- Publication type:
- Article
Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine‐Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1326, doi. 10.1002/cpt.2894
- By:
- Publication type:
- Article
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1315, doi. 10.1002/cpt.2891
- By:
- Publication type:
- Article
Dose Adjustment in Patients with Liver Cirrhosis – Comparison of Two Different Modeling Approaches.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1346, doi. 10.1002/cpt.2897
- By:
- Publication type:
- Article
3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1284, doi. 10.1002/cpt.2887
- By:
- Publication type:
- Article
Feasibility Study to Assess Canagliflozin Distribution and Sodium‐Glucose Co‐Transporter 2 Occupancy Using [<sup>18</sup>F]Canagliflozin in Patients with Type 2 Diabetes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1295, doi. 10.1002/cpt.2886
- By:
- Publication type:
- Article
Role of Cytochrome P450 2C8 in Drug–Drug Interaction between Amiodarone and Nirmatrelvir/Ritonavir Via Physiologically‐Based Pharmacokinetic Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1183, doi. 10.1002/cpt.2885
- By:
- Publication type:
- Article
A Structured Process to Identify Fit‐for‐Purpose Study Design and Data to Generate Valid and Transparent Real‐World Evidence for Regulatory Uses.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1235, doi. 10.1002/cpt.2883
- By:
- Publication type:
- Article
Development of an External Control Arm Using Electronic Health Record‐Based Real‐World Data to Evaluate the Efficacy of COVID‐19 Treatment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1274, doi. 10.1002/cpt.2882
- By:
- Publication type:
- Article
Comparison of Efficacy and Safety of Direct Oral Anticoagulants and Warfarin between Patients in Asian and Non‐Asian Regions: A Systematic Review and Meta‐Regression Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1240, doi. 10.1002/cpt.2881
- By:
- Publication type:
- Article
Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1268, doi. 10.1002/cpt.2877
- By:
- Publication type:
- Article
Corrigendum: Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH).
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1378, doi. 10.1002/cpt.2876
- Publication type:
- Article
Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1258, doi. 10.1002/cpt.2875
- By:
- Publication type:
- Article
Industry Perspective on Therapeutic Peptide Drug–Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1199, doi. 10.1002/cpt.2847
- By:
- Publication type:
- Article
A Comparison of FDA and EMA Pregnancy and Lactation Labeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1251, doi. 10.1002/cpt.2843
- By:
- Publication type:
- Article
Safety Monitoring of COVID‐19 Vaccines: Perspective from the European Medicines Agency.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1223, doi. 10.1002/cpt.2828
- By:
- Publication type:
- Article
Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1185, doi. 10.1002/cpt.2814
- By:
- Publication type:
- Article
The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1217, doi. 10.1002/cpt.2800
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1163, doi. 10.1002/cpt.2658
- Publication type:
- Article